Minivelle Approval History
- FDA approved: Yes (First approved October 29th, 2012)
- Brand name: Minivelle
- Generic name: estradiol
- Dosage form: Transdermal System
- Company: Noven Pharmaceuticals, Inc.
- Treatment for: Prevention of Osteoporosis, Postmenopausal Symptoms
Minivelle (estradiol) is an estrogen indicated for the treatment of moderate to severe vasomotor symptoms due to menopause, and for the prevention of postmenopausal osteoporosis.
Development History and FDA Approval Process for Minivelle
|Sep 24, 2014||Noven Receives FDA Approval of a New Indication with a New Dose for Minivelle|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.